We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Combining Genetic Screening Methods Saves Time

By Biotechdaily staff writers
Posted on 11 Nov 2002
A recently published report described the use of microarray technology that allowed efficient, objective, and quantitative evaluation of genes identified by quantitative trait locus (QTL) mapping and has the potential to reduce the overall effort needed in identifying genes causally associated with quantitative traits of interest. More...
The report appeared November 1, 2002, in the online edition of the Proceedings of the National Academy of Sciences.

Researchers from Purdue University (West Lafayette, IN, USA) and the University of Florida (Gainesville, USA) merged two established genetic-screening techniques in their study of the genetics of Drosophila ovarioles. They were attempting to identify the regions in the fruit fly genome containing the genes responsible for the number of ovarioles.

Drosophila has about 14,000 genes. Use of QTL mapping allowed the investigators to reduce the number of candidate genes first to about 5,000 and then, after refinement, down to a few hundred. Application of RNA microarray technology further trimmed this number down to 34.

The authors hope that the blending of technologies described in this study will serve as a guide to researchers seeking to save thousands of dollars and years of work in finding candidate genes for specific inherited diseases.



Related Links:
Purdue University
University of Florida

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
Chromogenic Culture System
InTray™ COLOREX™ ECC
Pipette Calibration System
Artel PCS®
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Alzheimer’s pathology can start 15 to 20 years before symptoms, and validated tools that reach patients earlier help pave the way for earlier detection. (Image Credit: Adobe Stock)

Alzheimer’s Blood Test Becomes First FDA-Cleared Option for Adults as Young as 40

C2N Diagnostics’ PrecivityAD2 blood test was cleared by the U.S. Food and Drug Administration (FDA) on August 20, 2026, for adults as young as 40 who are experiencing signs of cognitive impairment, according... Read more

Pathology

view channel
Image: Adrenal gland tumor stained with hematoxylin and eosin (top) and CYP11B2 (bottom) (Photo courtesy of Christofer Juhlin)

Simple Immunohistochemical Size Ratio Improves Classification of Primary Aldosteronism

Primary aldosteronism is a common but underdiagnosed cause of hypertension, in which excess aldosterone promotes salt retention and raises blood pressure. Identifying the dominant source of hormone overproduction... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.